$3.80
-0.21[-5.24%]
At close: Apr 19
$3.80
0[0.00%]
After Hours: 4:00PM EDT
Elevation Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Elevation Oncology using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | AM | ELEV | Q1 | -$0.50 | -$0.20 | — | — | $0.00 | — | — | — | Get Alert |
03/06/2024 | AM | ELEV | Q4 | -$0.82 | -$0.23 | -$0.19 | 17.39% | $0.00 | — | $0.00 | — | Get Alert |
11/02/2023 | AM | ELEV | Q3 | -$1.67 | -$0.32 | -$0.25 | 21.88% | $0.00 | — | $0.00 | — | Get Alert |
08/03/2023 | AM | ELEV | Q2 | -$0.86 | -$0.32 | -$0.37 | -15.62% | $0.00 | — | $0.00 | — | Get Alert |
05/15/2023 | AM | ELEV | Q1 | -$0.74 | -$0.59 | -$0.50 | 15.25% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2023 | AM | ELEV | Q4 | -$0.41 | -$0.78 | -$0.82 | -5.13% | $0.00 | — | $0.00 | — | Get Alert |
11/03/2022 | AM | ELEV | Q3 | -$0.53 | -$1.30 | -$1.67 | -28.46% | $0.00 | — | $0.00 | — | Get Alert |
08/04/2022 | AM | ELEV | Q2 | -$4.84 | — | -$0.86 | — | $0.00 | — | $0.00 | — | Get Alert |
05/05/2022 | AM | ELEV | Q1 | -$6.36 | — | -$0.74 | — | $0.00 | — | $0.00 | — | Get Alert |
03/03/2022 | AM | ELEV | Q4 | -$21.80 | — | -$0.41 | — | — | — | $0.00 | — | Get Alert |
11/12/2021 | AM | ELEV | Q3 | -$3.80 | -$0.38 | -$0.53 | -39.47% | $0.00 | — | $0.00 | — | Get Alert |
08/12/2021 | PM | ELEV | Q2 | — | — | -$4.84 | — | — | — | $0.00 | — | Get Alert |
Elevation Oncology (ELEV) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
The Actual EPS was $-0.19, which beat the estimate of $-0.23.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.